Scarica l'app Stockscreener
1.23
6.03%
0.07
Pre-mercato:
1.21
-0.02
-1.63%
Precedente Chiudi:
$1.16
Aprire:
$1.16
Volume 24 ore:
2.07M
Relative Volume:
0.61
Capitalizzazione di mercato:
$13.17M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-3.3324
EPS:
-0.3691
Flusso di cassa netto:
-
1 W Prestazione:
+155.82%
1M Prestazione:
+182.24%
6M Prestazione:
+27.98%
1 anno Prestazione:
-35.60%
Intervallo 1D:
$1.05
$1.35
Intervallo di 1 settimana:
$0.4872
$2.01
Portata 52W:
$0.387
$2.02
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
1.23 | 12.42M | 0 | 0 | 0 | -0.3691 |
TAK
Takeda Pharmaceutical Co Adr
|
15.66 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.09 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.33 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
548.27 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Gelteq Ltd Borsa (GELS) Ultime notizie
GELS Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
What's Going On With Gelteq Stock Friday?Gelteq (NASDAQ:GELS) - Benzinga
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - The Manila Times
Dogs accept gels that hide bitter medicine, Gelteq trials show - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
$Gelteq (GELS.US)$ 👍 sold all already. thank you![Drool][Cool Guy][Rich][Peace][Blessing] - Moomoo
Gelteq establishes Centre of Excellence in China to accelerate product development - BioSpectrum Asia
Gelteq establishes center of excellence in China’s Guangdong By Investing.com - Investing.com South Africa
Gelteq establishes center of excellence in China’s Guangdong - Investing.com
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - The Manila Times
Gelteq sets up Guangdong hub as China biotech deals near $60B - Stock Titan
Gelteq Limited announced that it expects to receive $3.5 million in funding - marketscreener.com
Gelteq (GELS) calls Special Meeting on convertible note share issuance and 9.99% cap - Stock Titan
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities - MSN
GELS - Finviz
Gelteq secures up to $3.5 million in convertible debt financing By Investing.com - Investing.com India
Gelteq secures up to $3.5 million in convertible debt financing - Investing.com
Gelteq (NASDAQ: GELS) inks up to $3.5M structured convertible note deal - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Gelteq begins clinical trial for veterinary antiparasitic drug - Investing.com
Gelteq begins clinical trial for veterinary antiparasitic drug By Investing.com - Investing.com South Africa
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - The Manila Times
Inside Gelteq’s first vet drug trial in a $78B animal health market - Stock Titan
Gelteq secures up to $3.5M debt financing to support commercialization - MSN
Sommer Ray’s Imaraïs taps Healthy Extracts to make 4M beauty gummies - Stock Titan
TradingKey - TradingKey
Gelteq announces USD $3.5 million strategic debt financing to accelerate commercialization and support revenue growth - marketscreener.com
Gelteq Secures USD $3.5 Million in Debt Financing on May 12, 2026 - geneonline.com
Gelteq secures up to $3.5M debt financing for trials - Investing.com
Gelteq secures up to $3.5M debt financing for trials By Investing.com - Investing.com India
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - marketscreener.com
Gelteq lands $3.5M to speed its pharmaceutical and nutraceutical gels - Stock Titan
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - MSN
What makes Gelteq Limited (GELS) a compelling holding for the long term (Hovering) 2026-05-08Trending Entry Points - Newser
What Gelteq Limited (GELS) is doing that smarter investors notice (Institutional Selling) 2026-05-05Social Buzz - Newser
GELS Price Today: Gelteq Limited Stock Price, Quote & Chart | MEXC - MEXC Exchange
GELS (Gelteq Limited) management prioritizes emerging tech vertical investments to drive future sustainable revenue growth.Expert Momentum Signals - Newser
Simon H Szewach Net Worth (2026) - GuruFocus
Bradley Glenn Karp Net Worth (2026) - GuruFocus
Nathan J Givoni Net Worth (2026) - GuruFocus
Paul Michael Wynne Net Worth (2026) - GuruFocus
ETF Watch: Is Gelteq Limited likely to announce a buyback2026 Earnings Surprises & Low Risk High Reward Ideas - baoquankhu1.vn
Market Review: How liquid is Gelteq Limited stockExit Point & Consistent Income Trade Recommendations - baoquankhu1.vn
What support levels matter for Gelteq Limited (GELS) Stock | Price at $0.75, Up 13.12%Trending Momentum Stocks - Newser
Gelteq Ltd (GELS) Cash Flow - TradingKey
Will Gelteq Limited (GELS) Stock Outperform Peers | Price at $0.70, Up 3.09%Stock Analysis Community - Newser
GELS PE Ratio & Valuation, Is GELS Overvalued - Intellectia AI
Five straight record quarters set up Healthy Extracts for a bigger 2026 - Stock Titan
Short Interest in Gelteq Limited Drops 26.3% in March - National Today
Gelteq Ltd Azioni (GELS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):